Thermo Fisher Scientific logged a 0.3% change during today's afternoon session, and is now trading at a price of $468.72 per share. On average, analysts give it a target price of $606.88.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The large-cap company is based in the United States. Thermo Fisher Scientific currently returns an annual dividend yield of 0.3%.
What to Consider if You Are Thinking of Buying Thermo Fisher Scientific:
-
Thermo Fisher Scientific has moved -4.0% over the last year.
-
TMO has a forward P/E ratio of 19.3 based on its EPS guidance of 24.31.
-
Over the last 6 years, earnings per share (EPS) have been growing at a compounded average rate of 21.1%.
-
The company has a price to earnings growth (PEG) ratio of 3.72.
-
Its Price to Book (P/B) ratio is 4.13
Thermo Fisher Scientific Has Irregular Cash Flows
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-02-23 | 9,154,000 | -2,219,000 | 11,373,000 | -3.74 |
| 2022-02-24 | 9,312,000 | -2,503,000 | 11,815,000 | 21.12 |
| 2021-02-25 | 8,289,000 | -1,466,000 | 9,755,000 | 66.38 |
| 2020-02-26 | 4,973,000 | -890,000 | 5,863,000 | 11.65 |
| 2019-02-27 | 4,543,000 | -708,000 | 5,251,000 | 16.53 |
| 2018-02-28 | 4,005,000 | -501,000 | 4,506,000 |
Thermo Fisher Scientific's free cash flows have a decent average of $8.09 Billion over the last 6 years, but they are highly variable since their coefficient of variability is 17498678813.6%. The compounded average growth rate over this period is 0.0%.
